SCHEMBL13305133

SCHEMBL13305133

Bc1cnn2c(C)cc(C3CCN(C(=O)OCc4ccccc4)CC3)nc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPC3 Q13507 3/20 0.53
▸ TRPC7 Q9HCX4 3/20 0.53
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ NPC1 O15118 2/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ CYP2C19 P33261 1/20 0.46
▸ KDM4E B2RXH2 4/20 0.46
▸ HPGD P15428 3/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.43
▸ PRMT5 O14744 1/20 0.43
▸ GRIN2B Q13224 6/20 0.43
▸ USP30 Q70CQ3 1/20 0.43
▸ HTT P42858 2/20 0.43
▸ CYP2D6 P10635 3/20 0.42
▸ CYP2C9 P11712 3/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12953919 0.89 TRPC3 (0.53) TRPC3TRPC7SMN1; SMN2NPC1RAB9A
SCHEMBL13305198 0.82 GSK3B (0.56) TRPC3TRPC7GRIN2BCYP2D6CYP2C9
SCHEMBL14043203 0.82 TRPC3 (0.44) TRPC3TRPC7SMN1; SMN2NPC1RAB9A
SCHEMBL13305058 0.81 TRPC3 (0.57) TRPC3TRPC7SMN1; SMN2NPC1RAB9A
SCHEMBL13305009 0.79 USP30 (0.45) TRPC3TRPC7SMN1; SMN2NPC1RAB9A
SCHEMBL13901218 0.79 TRPC3 (0.53) TRPC3TRPC7SMN1; SMN2NPC1RAB9A
SCHEMBL13304833 0.79 CA2 (0.52) TRPC3TRPC7SMN1; SMN2RAB9ACYP2C19
SCHEMBL13993128 0.78 TRPC3 (0.49) TRPC3TRPC7SMN1; SMN2NPC1RAB9A
SCHEMBL13901344 0.78 TRPC3 (0.53) TRPC3TRPC7SMN1; SMN2NPC1RAB9A
SCHEMBL12953546 0.78 TRPC3 (0.53) TRPC3TRPC7SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537116-B1 PYRAZOLOPYRIMIDINES SUITABLE FOR THE TREATMENT OF CANCER DISEASES SCHERING CORP (US) 2010-06-02 — — EP disclosed
Send feedback